Page 21 - TD-3-2

Tumor Discovery Volatile organic compounds for cancer screening

beyond [published correction appears in Nat Rev Cancer. detection in patients with cutaneous melanoma. Cancer.
2010;10(8):593]. Nat Rev Cancer. 2010;10(6):403-414. 2000;89(2):342-347.
doi: 10.1038/nrc2857 doi: 10.1002/1097-0142
69. Tong H, Wang Y, Li Y, et al. Volatile organic metabolites 79. Carli P, De Giorgi V, Palli D, et al. Self-detected cutaneous
identify patients with gastric carcinoma, gastric ulcer, or melanomas in Italian patients. Clin Exp Dermatol.
gastritis and control patients. Cancer Cell Int. 2017;17:108. 2004;29(6):593-596.
doi: 10.1186/s12935-017-0475-x doi: 10.1111/j.1365-2230.2004.01628.x
70. Pham YL, Beauchamp J. Breath biomarkers in diagnostic 80. Gachon J, Beaulieu P, Sei JF, et al. First prospective study
applications. Molecules. 2021;26(18):5514. of the recognition process of melanoma in dermatological
practice. Arch Dermatol. 2005;141(4):434-438.
doi: 10.3390/molecules26185514
doi: 10.1001/archderm.141.4.434
71. Kumar S, Huang J, Abbassi-Ghadi N, Španěl P, Smith D,
Hanna GB. Selected ion flow tube mass spectrometry analysis 81. Dinnes J, Deeks JJ, Grainge MJ, et al. Visual inspection
of exhaled breath for volatile organic compound profiling of for diagnosing cutaneous melanoma in adults. Cochrane
esophago-gastric cancer. Anal Chem. 2013;85(12):6121-6128. Database Syst Rev. 2018;12(12):CD013194.
doi: 10.1021/ac4010309 doi: 10.1002/14651858.CD013194
72. Kumar S, Huang J, Abbassi-Ghadi N, et al. Mass spectrometric 82. Kwak J, Gallagher M, Ozdener MH, et al. Volatile biomarkers
analysis of exhaled breath for the identification of volatile from human melanoma cells. J Chromatogr B Analyt Technol
organic compound biomarkers in esophageal and gastric Biomed Life Sci. 2013;931:90-96.
adenocarcinoma. Ann Surg. 2015;262(6):981-990. doi: 10.1016/j.jchromb.2013.05.007

doi: 10.1097/SLA.0000000000001101 83. Santonico M, D’Amico A, Di Natale C. Investigations on
73. Xiang L, Wu S, Hua Q, Bao C, Liu H. Volatile organic Odor-Pathology Relationship in Humans, Thesis, Department
compounds in human exhaled breath to diagnose of Electronic Engineering, University of Rome; 2007.
gastrointestinal cancer: A meta-analysis. Front Oncol. 84. Abaffy T, Möller MG, Riemer DD, Milikowski C,
2021;11:606915. DeFazio RA. Comparative analysis of volatile metabolomics
doi: 10.3389/fonc.2021.606915 signals from melanoma and benign skin: A pilot study.
Metabolomics. 2013;9:998-1008.
74. Durán-Acevedo CM, Jaimes-Mogollón AL, Gualdrón-
Guerrero OE, et al. Exhaled breath analysis for gastric doi: 10.1007/s11306-013-0523-z
cancer diagnosis in Colombian patients. Oncotarget. 85. Lawrence W Jr., Donegan WL, Natarajan N, Mettlin C,
2018;9(48):28805-28817. Beart R, Winchester D. Adult soft tissue sarcomas. A pattern
doi: 10.18632/oncotarget.25331 of care survey of the American College of Surgeons. Ann
Surg. 1987;205(4):349-359.
75. Jung YJ, Seo HS, Kim JH, Song KY, Park CH, Lee HH.
Advanced diagnostic technology of volatile organic doi: 10.1097/00000658-198704000-00003
compounds real time analysis analysis from exhaled breath of 86. Alcindor T, Dumitra S, Albritton K, et al. Disparities in cancer
gastric cancer patiens using proton-transfer-reaction time- care: The example of sarcoma-in search of solutions for a
of-flight mass spectrometry. Front Oncol. 2021;11:560591. global issue. Am Soc Clin Oncol Educ Book. 2021;41:405-411.

doi: 10.3389/fonc.2021.560591 doi: 10.1200/EDBK_32046
76. Yang H, Xiang C, Mou Y, et al. The investigation of volatile 87. von Mehren M, Randall RL, Benjamin RS, et al. Soft tissue
organic compounds in diagnosing (early) esophageal sarcoma, version 2.2018, NCCN clinical practice guidelines
squamous cell carcinoma and gastric adenocarcinoma. in oncology. J Natl Compr Canc Netw. 2018;16(5):536-563.
J Cancer Res Clin Oncol. 2023;149(10):7029-7041.
doi: 10.6004/jnccn.2018.0025
doi: 10.1007/s00432-023-04595-4
88. Rupani A, Hallin M, Jones R.L, et al. Diagnostic differences
77. Green AC, Baade P, Coory M, Aitken JF, Smithers M. in expert second-opinion consultation cases at a tertiary
Population-based 20-year survival among people diagnosed sarcoma center. Sarcoma. 2020;2020:9810170.
with thin melanomas in Queensland, Australia. J Clin Oncol. doi: 10.1155/2020/9810170
2012;30(13):1462-1467.
89. Soomers VLMN, Husson O, Desar IME, et al. Patient and
doi: 10.1200/JCO.2011.38.8561
diagnostic intervals of survivors of sarcoma: Results from
78. Brady MS, Oliveria SA, Christos PJ, et al. Patterns of the SURVSARC study. Cancer. 2020;126(24):5283-5292.

Volume 3 Issue 2 (2024) 15 doi: 10.36922/td.2061